C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2006
11/15/2006	CN1861581A Preparation of allantoin and allantoin extract from cistanche salsa and their use thereof
11/15/2006	CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/15/2006	CN1284777C 5-membered heterocycles, preparation and use thereof as medicine
11/15/2006	CN1284774C Process for distilling alkaline caprolactam product at reduced pressure
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/14/2006	US7135493 HDAC inhibitor
11/14/2006	US7135492 Increases the concentration of high density lipoprotein cholesterol in the blood; dyslipoproteinemia; angina pectoris, myocardial infarction, antiarrhythmia agents, heart failure, kidney failure stroke, peripheral arterial occulsion
11/14/2006	US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/14/2006	US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy.
11/14/2006	US7135047 N-2-(morpholine-4-yl)ethyl-m-phenylenediamine, N-3-(morpholine-4-yl)propyl-m-phenylenediamine, and N-3-(imidazole-1-yl)-propyl-m-phenylenediamine; high color intensities, good light fastness and washing fastness properties, and a good equalization capability
11/14/2006	CA2111386C Substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/09/2006	WO2006119411A1 Insecticidal substituted aminoalkyl heterocyclic and heteroaryl derivatives
11/09/2006	WO2006117162A2 Method for impregnating lignocellulosic materials with effect agents
11/09/2006	WO2006117159A1 Aqueous, hardenable compositions for impregnating lignocellulosic materials
11/09/2006	WO2006067215A3 Intermediate compounds for the preparation of angiotensin ii receptor antagonists
11/09/2006	US20060252811 Substituted benzylimidazoles useful for the treatment of inflammatory diseases
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	US20060252760 Farnesyl transferase inhibitors
11/09/2006	CA2606781A1 Method for impregnating lignocellulosic materials with effect agents
11/08/2006	EP1719764A1 Method of asymmetrically reducing 4- 5-(imidazol-1-yl)-2-met hylbenzoyl -3,5-dimethyl-benzoic acid or ester thereof
11/08/2006	EP1718342A1 Technetium-and rhenium-bis(heteroaryl) complexes, and methods of use thereof
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	CN1858039A Synthetic method for 1-amino-3 (azacyclo alkyl)-2, 4-imidazole diketone
11/08/2006	CN1283610C Ketone compounds and compositions for cholesterol management and related uses
11/07/2006	US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimers, Parkinsons, Lesche-Nyhane, Wilsons, and Tourettes syndrome
11/07/2006	US7132548 Process for recovering 1,3-dimethyl-2-imidazolidinone
11/07/2006	US7132544 Process for the preparation of tetrasubstituted imidazole derivatives and novel crystalline structures thereof
11/07/2006	US7132457 Adamantane derivatives
11/07/2006	US7132422 An aromatic-oxy-alkyleneamine derivative, useful for treating neuropathic pain
11/07/2006	US7132421 Antiproliferative agnets
11/07/2006	CA2130703C Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them
11/02/2006	WO2006116007A2 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
11/02/2006	WO2006114264A1 Acetylene derivatives
11/02/2006	WO2006114262A1 Acetylene derivatives
11/02/2006	WO2006114260A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/02/2006	WO2006089664A3 Heterocyclylamide-substituted imidazoles
11/02/2006	WO2006059149A8 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
11/02/2006	WO2005041899A3 Orally available sphingosine 1-phosphate receptor agonists and antagonists
11/02/2006	WO2005028624A3 Molecular scaffolds for kinase ligand development
11/02/2006	US20060247289 Certain chemical entities, compositions, and methods
11/02/2006	US20060247219 Specific glucocorticosteriod compound having anti-inflamatory activity
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006	EP1399117B1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
11/02/2006	EP1194144B1 Antibacterial compounds
11/02/2006	CA2605267A1 Acetylene derivatives
11/02/2006	CA2605265A1 Acetylene derivatives
11/02/2006	CA2605262A1 Phenylacetylene derivatives having mglur5 receptor affinity
11/01/2006	CN1856479A Gamma-secretase inhibitors
11/01/2006	CN1854206A Process for preparation of alkylimidazolidone (meth)acrylates
11/01/2006	CN1854129A Superhigh purity ionic liquid
11/01/2006	CN1854128A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/01/2006	CN1282640C N-arylphenylacetamide derivatives and medicinal compositions containing same
10/2006
10/31/2006	US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions
10/31/2006	US7129361 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
10/31/2006	US7129359 for treating infection by enterovirus of the Picornaviridae family ; exemplified by: 1-[2-(4'-Chloro-biphenyl-4-yloxymethyl)-benzyl]-3-pyridin-4-yl-imidazolidin-2-one
10/31/2006	US7129251 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
10/31/2006	CA2262906C Novel immunotherapeutic agents and their use in the reduction of cytokine levels
10/31/2006	CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/26/2006	WO2006111346A1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
10/26/2006	WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
10/26/2006	WO2003006628A3 Nad synthetase inhibitors and uses thereof
10/26/2006	US20060241306 Process for the synthesis of functionalized indolizidines
10/26/2006	US20060241302 Morpholine derivatives
10/26/2006	US20060241298 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof
10/26/2006	US20060241180 Selective androgen receptor modulators and methods of use thereof
10/26/2006	US20060241162 Optically active (R)-hydantoin derivative
10/26/2006	US20060241157 Heterocyclic ppar modulators
10/26/2006	US20060241155 TNF-alpha production inhibitors
10/26/2006	US20060241152 Imidazoline derivatives having CB1-antagonistic activity
10/26/2006	US20060241140 Imidazolamino compounds
10/26/2006	US20060241129 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
10/26/2006	DE102005018191A1 Substituierte zyklische Harnstoff-Derivate und deren Verwendung zur Herstellung von Arzneimitteln Substituted cyclic urea derivatives and their use for the preparation of medicaments
10/26/2006	CA2605144A1 Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
10/25/2006	EP1713780A2 Novel inhibitors of glutaminyl cyclase
10/25/2006	EP1713515A1 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
10/25/2006	CN1852898A Ionic liquid and method of reaction using the same
10/25/2006	CN1850806A Method for preparing secnidazole
10/25/2006	CN1850805A Method for preparing imidazophenylurea hydrochloride
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity
10/24/2006	US7126001 Antiproliferative agents; antitumor agents
10/24/2006	US7125996 Fluorescent probes for use in protein kinase inhibitor binding assay
10/24/2006	US7125904 Cardiovascular disorders; hypotensive agents; congestive heart failure
10/24/2006	US7125891 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins
10/24/2006	US7125879 Prevention reproduction of virus
10/24/2006	US7125875 Cyclic protein tyrosine kinase inhibitors
10/24/2006	US7125871 Excitatory amino acid receptor modulators
10/24/2006	CA2262451C Boronic compound complexing reagents and complexes
10/24/2006	CA2261848C Cell adhesion inhibitors
10/24/2006	CA2168023C Vasoconstrictive substituted aryloxyalkyl diamines
10/19/2006	WO2006108910A1 Detomidine hydrochloride crystallization method
10/19/2006	WO2006108224A1 Antiparasitic compounds
10/19/2006	US20060235220 Dipeptide nitriles
10/19/2006	US20060235049 1-{3-[4-(1-Methyl-pyrrolidin-2-yl)-phenoxy]-propyl}-piperidine, and 1-Benzyl-4-[4-(3-piperidin-1-yl-propoxy)-phenyl]-piperidin-4-ol; histamin receptor antagonist; antidepressant; upper airway allergies, nasal congestion, allergic rhinitis, cognitive dysfunction, schizophrenia, manic disorders
10/19/2006	US20060235035 Novel methoxybenzamibe compounds for use in mch receptor related disorders
10/19/2006	US20060235027 Inhibitors of cdc25 phosphatases
10/19/2006	DE112004001729T5 Ionische Flüssigkeit und Reaktionsverfahren, das dieselbe einsetzt Ionic liquid and reaction method using the same
10/18/2006	EP1711617A1 Method and compositions for identifying anti-hiv therapeutics compounds
10/18/2006	EP1711473A1 Substituted n-cyclohexylimidazolinones having an mch-modulatory effect

1 ... 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 ... 345